curacle co.,ltd.

A365270

KR7365270008

Biotechnology & Medical Research

End-of-day quote Korea S.E. Other stock markets 06:00:00 2024-04-25 pm EDT			5-day change	1st Jan Change
18,780 ^KRW	+3.07%		+5.51%	+61.48%

2023	Curacle Co., Ltd. announced that it has received KRW 20 billion in funding from a group of investors	CI
2023	Curacle Co., Ltd. announced that it expects to receive KRW 20 billion in funding from a group of investors	CI

Curacle Co., Ltd.(KOSDAQ:A365270) added to S&P Global BMI Index

December 20, 2021 at 12:00 am EST

Latest news about curacle co.,ltd.

Curacle Co., Ltd. announced that it has received KRW 20 billion in funding from a group of investors	23-06-27	CI
Curacle Co., Ltd. announced that it expects to receive KRW 20 billion in funding from a group of investors	23-06-25	CI
Curacle Co., Ltd.(KOSDAQ:A365270) added to S&P Global BMI Index	21-12-20	CI
Curacle and Th?a Announce Licensing and Collaboration Agreement for the Development and Commercialization of Orally Administered Treatment for Diabetic Macular Edema and Wet-AMD	21-10-27	CI

Curacle Co Ltd is a Korea-based company primarily engaged in the development of therapeutics for intractable vascular and metabolic diseases. The Company researches and develops synthetic drugs CU06-RE, CU01, and natural drug CU03 as new drugs for intractable vascular diseases. The Companyâs drugs are used for diabetic macular edema (DME), diabetic nephropathy (DN), and wet age-related macular degeneration (wet AMD). In addition, the Company uses the SOLVADYS platform technology, a platform technology for the development of vascular endothelial dysfunction blockers.

Sector

Biotechnology & Medical Research

Calendar

2024-05-12 - Q1 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Sector Bio Therapeutic Drugs

	1st Jan change	Capi.
CURACLE CO.,LTD.	+61.48%	189M
VERTEX PHARMACEUTICALS INCORPORATED	-2.31%	103B
REGENERON PHARMACEUTICALS, INC.	+0.56%	95.28B
ARGENX SE	+1.69%	22.15B
BIONTECH SE	-17.37%	21.02B
GENMAB A/S	-9.30%	18.15B
WUXI APPTEC CO., LTD.	-41.01%	16.74B
BEIGENE, LTD.	-14.85%	16.05B
NEUROCRINE BIOSCIENCES, INC.	+3.21%	13.68B
SAREPTA THERAPEUTICS, INC.	+33.54%	12.17B